CD8A and ovarian carcinoma: As in vitro functional studies showed the increased anticancer effect of CD8+ T cells on ovarian cancer cells after co-treatment with compound 968 and anti-PD-L1 antibody (Figure 3), we next explored whether similar effects would be seen in the xenograft model using C57BL/6J mice.